Current Pharmaceutical Design,volume 17,issue 34  (01-2011)

Period of time： 2011年34期

Publisher： Bentham Science Publishers

Founded in： 1995

Total resources： 625

E-ISSN： 1873-4286|17|34

ISSN： 1381-6128

Subject： R9 Pharmacy

Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Current Pharmaceutical Design,volume 17,issue 34

Menu

Editorial [Hot Topic: Targeting Mast Cells and Basophils in Allergy and Beyond: Emerging Concepts (Executive Guest Editor: Petr Heneberg)]

Current Pharmaceutical Design,volume 17,issue 34 , Vol. 17, Iss. 34, 2011-11 , pp. 3741-3743

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Targeting Cardiac Mast Cells: Pharmacological Modulation of the Local Renin-Angiotensin System

Current Pharmaceutical Design,volume 17,issue 34 , Vol. 17, Iss. 34, 2011-11 , pp. 3744-3752

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Mast Cells and Basophils: Trojan Horses of Conventional Lin- Stem/Progenitor Cell Isolates

Current Pharmaceutical Design,volume 17,issue 34 , Vol. 17, Iss. 34, 2011-11 , pp. 3753-3771

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Mast Cells in Tissue Healing: From Skin to the Gastrointestinal Tract

Current Pharmaceutical Design,volume 17,issue 34 , Vol. 17, Iss. 34, 2011-11 , pp. 3772-3775

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

IL-19 as a Potential Therapeutic in Autoimmune and Inflammatory Diseases

Current Pharmaceutical Design,volume 17,issue 34 , Vol. 17, Iss. 34, 2011-11 , pp. 3776-3780

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Interleukin-25: Key Regulator of Inflammatory and Autoimmune Diseases

Current Pharmaceutical Design,volume 17,issue 34 , Vol. 17, Iss. 34, 2011-11 , pp. 3781-3785

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

CD164 as a Basophil Activation Marker

Current Pharmaceutical Design,volume 17,issue 34 , Vol. 17, Iss. 34, 2011-11 , pp. 3786-3796

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Mast Cells as Sources and Targets of Membrane Vesicles

Current Pharmaceutical Design,volume 17,issue 34 , Vol. 17, Iss. 34, 2011-01 , pp. 3797-3804

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Autoimmunity-Inducing Metals (Hg, Au and Ag) Modulate Mast Cell Signaling, Function and Survival

Current Pharmaceutical Design,volume 17,issue 34 , Vol. 17, Iss. 34, 2011-01 , pp. 3805-3814

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

PIP3 Regulation as Promising Targeted Therapy of Mast-Cell-Mediated Diseases

Current Pharmaceutical Design,volume 17,issue 34 , Vol. 17, Iss. 34, 2011-11 , pp. 3815-3822

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Previous 1 2 Next Display item(s) per page Total 12 item(s)